CLINICAL_TRIALS
trial_result
· 2016-01-08
Clinical Trial Update: Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients [Phase 3]
Summary
A Phase 3 trial of bapineuzumab in Alzheimer's disease was terminated; results were posted January 8, 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Alzheimer Disease | Phase 3 | Status: TERMINATED | Results posted: 2016-01-08